Astrocyte metabolism and signaling during brain ischemia

Nature Neuroscience

Volumn 10, Issue 11, 2007, Pages 1377-1386

  Rossi, David J ^a   Brady, James D ^a   Mohr, Claudia ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE TRIPHOSPHATE; DEXTRO SERINE; GLUCOSE; GLUTAMIC ACID; GLYCOGEN; NEUROTRANSMITTER; OXYGEN; PURINE; SERINE;

ASTROCYTE; BRAIN DAMAGE; BRAIN ISCHEMIA; CELL FUNCTION; CELL METABOLISM; GAP JUNCTION; HUMAN; HYPOGLYCEMIA; LACTIC ACIDOSIS; MEMBRANE VESICLE; NERVE CELL NETWORK; NEUROTRANSMITTER RELEASE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; STROKE; TRANSPORT KINETICS;

ANIMALS; ASTROCYTES; BRAIN ISCHEMIA; HUMANS; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION;

EID: 35548957889     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/nn2004     Document Type: Review

References (100)

1. Choi, D.W. & Rothman, S.M. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu. Rev. Neurosci. 13, 171-182 (1990).
2. Lipton, P. Ischemic cell death in brain neurons. Physiol. Rev. 79, 1431-1568 (1999).
3. Silver, I.A., Deas, J. & Erecinska, M. Ion homeostasis in brain cells: differences in intracellular ion responses to energy limitation between cultured neurons and glial cells. Neuroscience 78, 589-601 (1997).
4. Abramov, A.Y., Scorziello, A. & Duchen, M.R. Three distinct mechanisms generate oxygen free radicals in neurons and contribute to cell death during anoxia and reoxygenation. J. Neurosci. 27, 1129-1138 (2007).
5. Lowry, O.H., Passonneau, J.V., Hasselberger, F.X. & Schulz, D.W. Effect of ischemia on known substrates and cofactors of the glycolytic pathway in brain. J. Biol. Chem. 239, 18-30 (1964).
6. Hansen, A.J. & Nedergaard, M. Brain ion homeostasis in cerebral ischemia. Neurochem. Pathol. 9, 195-209 (1988).
7. Kraig, R.P., Ferreira-Filho, C.R. & Nicholson, C. Alkaline and acid transients in cerebellar microenvironment. J. Neurophysiol. 49, 831-850 (1983).
8. Phillis, J.W., Smith-Barbour, M. & O'Regan, M.H. Changes in extracellular amino acid neurotransmitters and purines during and following ischemias of different durations in the rat cerebral cortex. Neurochem. Int. 29, 115-120 (1996).
9. Rossi, D.J., Oshima, T. & Attwell, D. Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature 403, 316-321 (2000).
10. 2+ regulation. J. Neural Transm. Suppl. 44, 73-85 (1994).
11. Duffy, S. & MacVicar, B.A. In vitro ischemia promotes calcium influx and intracellular calcium release in hippocampal astrocytes. J. Neurosci. 16, 71-81 (1996).
12. Arundine, M. & Tymianski, M. Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell. Mol. Life Sci. 61, 657-668 (2004).
13. Nicholls, D.G., Johnson-Cadwell, L., Vesce, S., Jekabsons, M., & Yadava, N. Bioenergetics of mitochondria in cultured neurons and their role in glutamate excitotoxicity. J. Neurosci. Res. 23 April 2007 (doi:10.1002/jnr.21290).
14. Pulsinelli, W.A. Selective neuronal vulnerability: morphological and molecular characteristics. Prog. Brain Res. 63, 29-37 (1985).
15. Higuchi, T., Takeda, Y., Hashimoto, M., Nagano, O. & Hirakawa, M. Dynamic changes in cortical NADH fluorescence and direct current potential in rat focal ischemia: relationship between propagation of recurrent depolarization and growth of the ischemic core. J. Cereb. Blood Flow Metab. 22, 71-79 (2002).
16. Nedergaard, M. & Hansen, A.J. Characterization of cortical depolarizations evoked in focal cerebral ischemia. J. Cereb. Blood Flow Metab. 13, 568-574 (1993).
17. Feustel, P.J., Jin, Y. & Kimelberg, H.K. Volume-regulated anion channels are the predominant contributors to release of excitatory amino acids in the ischemic cortical penumbra. Stroke 35, 1164-1168 (2004).
18. Xie, M., Wang, W., Kimelberg, H.K. & Zhou, M. Oxygen and glucose deprivation-induced changes in astrocyte membrane potential and their underlying mechanisms in acute rat hippocampal slices. J. Cereb. Blood Flow Metab. 22 August 2007 (doi:10.1038/5j.jcbfm.9600545).
19. Brown, A.M. Brain glycogen re-awakened. J. Neurochem. 89, 537-552 (2004).
20. Suh, S.W. et al. Astrocyte glycogen sustains neuronal activity during hypoglycemia: studies with the glycogen phosphorylase inhibitor CP-316,819 ([R-R*,S*]-5-chloro-N-[2-hydroxy-3- (methoxymethylamino)-3-oxo-1-(phenylmethyl)propyl]-1H-indole-2-carboxamide). J. Pharmacol. Exp. Ther. 321, 45-50 (2007).
21. Brown, A.M. et al. Astrocyte glycogen metabolism is required for neural activity during aglycemia or intense stimulation in mouse white matter. J. Neurosci. Res. 79, 74-80 (2005).
22. Ransom, B.R. & Fern, R. Does astrocytic glycogen benefit axon function and survival in CNS white matter during glucose deprivation? Glia 21, 134-141 (1997).
23. Magistretti, P.J. Neuron-glia metabolic coupling and plasticity. J. Exp. Biol. 209, 2304-2311 (2006).
24. Tekkok, S.B., Brown, A.M., Westenbroek, R., Pellerin, L. & Ransom, B.R. Transfer of glycogen-derived lactate from astrocytes to axons via specific monocarboxylate transporters supports mouse optic nerve activity. J. Neurosci. Res. 81, 644-652 (2005).
25. Silver, I.A. & Erecinska, M. Extracellular glucose concentration in mammalian brain: continuous monitoring of changes during increased neuronal activity and upon limitation in oxygen supply in normo-, hypo-, and hyperglycemic animals. J. Neurosci. 14, 5068-5076 (1994).
26. Lindsberg, P.J. & Roine, R.O. Hyperglycemia in acute stroke. Stroke 35, 363-364 (2004).
27. Folbergrova, J., Li, P.A., Uchino, H., Smith, M.L. & Siesjo, B.K. Changes in the bioenergetic state of rat hippocampus during 2.5 min of ischemia, and prevention of cell damage by cyclosporin A in hyperglycemic subjects. Exp. Brain Res. 114, 44-50 (1997).
28. Li, P.A., Kristian, T., Shamloo, M. & Siesjo, K. Effects of preischemic hyperglycemia on brain damage incurred by rats subjected to 2.5 or 5 minutes of forebrain ischemia. Stroke 27, 1592-1601 (1996).
29. Li, P.A., Shamloo, M., Katsura, K., Smith, M.L. & Siesjo, B.K. Critical values for plasma glucose in aggravating ischaemic brain damage: correlation to extracellular pH. Neurobiol. Dis. 2, 97-108 (1995).
30. Li, P.A. & Siesjo, B.K. Role of hyperglycaemia-related acidosis in ischaemic brain damage. Acta Physiol. Scand. 161, 567-580 (1997).
31. Schurr, A. Bench-to-bedside review: a possible resolution of the glucose paradox of cerebral ischemia. Crit. Care 6, 330-334 (2002).
32. Chesler, M. Failure and function of intracellular pH regulation in acute hypoxic-ischemic injury of astrocytes. Glia 50, 398-406 (2005).
33. Xiong, Z.G. et al. Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels. Cell 118, 687-698 (2004).
34. Uyttenboogaart, M. et al. Moderate hyperglycaemia is associated with favourable outcome in acute lacunar stroke. Brain 130, 1626-1630 (2007).
35. Dawson, D.A., Wadsworth, G. & Palmer, A.M. A comparative assessment of the efficacy and side-effect liability of neuroprotective compounds in experimental stroke. Brain Res. 892, 344-350 (2001).
36. Devuyst, G. & Bogousslavsky, J. Update on recent progress in drug treatment for acute ischemic stroke. J. Neurol. 248, 735-742 (2001).
37. Lo, E.H., Singhal, A.B., Torchilin, V.P. & Abbott, N.J. Drug delivery to damaged brain. Brain Res. Brain Res. Rev. 38, 140-148 (2001).
38. Chen, H.S. & Lipton, S.A. The chemical biology of clinically tolerated NMDA receptor antagonists. J. Neurochem. 97, 1611-1626 (2006).
39. Astrup, J., Symon, L., Branston, N.M. & Lassen, N.A. Cortical evoked potential and extracellular K+ and H+ at critical levels of brain ischemia. Stroke 8, 51-57 (1977).
40. Katchman, A.N. & Hershkowitz, N. Early anoxia-induced vesicular glutamate release results from mobilization of calcium from intracellular stores. J. Neurophysiol. 70, 1-7 (1993).
41. Haydon, P.G. & Carmignoto, G. Astrocyte control of synaptic transmission and neurovascular coupling. Physiol. Rev. 86, 1009-1031 (2006).
42. Montana, V., Malarkey, E.B., Verderio, C., Matteoli, M. & Parpura, V. Vesicular transmitter release from astrocytes. Glia 54, 700-715 (2006).
43. Gallagher, C.J. & Salter, M.W. Differential properties of astrocyte calcium waves mediated by P2Y1 and P2Y2 receptors. J. Neurosci. 23, 6728-6739 (2003).
44. Queiroz, G., Meyer, D.K., Meyer, A., Starke, K. & von Kügelgen, I. A study of the mechanism of the release of ATP from rat cortical astroglial cells evoked by activation of glutamate receptors. Neuroscience 91, 1171-1181 (1999).
45. Bal-Price, A., Moneer, Z. & Brown, G.C. Nitric oxide induces rapid, calcium-dependent release of vesicular glutamate and ATP from cultured rat astrocytes. Glia 40, 312-323 (2002).
46. Melani, A. et al. ATP extracellular concentrations are increased in the rat striatum during in vivo ischemia. Neurochem. Int. 47, 442-448 (2005).
47. Parkinson, F.E. & Xiong, W. Stimulus- and cell-type-specific release of purines in cultured rat forebrain astrocytes and neurons. J. Neurochem. 88, 1305-1312 (2004).
48. Duan, S. et al. P2X7 receptor-mediated release of excitatory amino acids from astrocytes. J. Neurosci. 23, 1320-1328 (2003).
49. Parpura, V., Scemes, E. & Spray, D.C. Mechanisms of glutamate release from astrocytes: gap junction "hemichannels", purinergic receptors and exocytotic release. Neurochem. Int. 45, 259-264 (2004).
50. Lammer, A. et al. Neuroprotective effects of the P2 receptor antagonist PPADS on focal cerebral ischaemia-induced injury in rats. Eur. J. Neurosci. 23, 2824-2828 (2006).
51. Rudolphi, K.A., Schubert, P., Parkinson, F.E. & Fredholm, B.B. Neuroprotective role of adenosine in cerebral ischaemia. Trends Pharmacol. Sci. 13, 439-445 (1992).
52. Martin, E.D. et al. Adenosine released by astrocytes contributes to hypoxia-induced modulation of synaptic transmission. Glia 55, 36-45 (2007).
53. Fellin, T. et al. Neuronal synchrony mediated by astrocytic glutamate through activation of extrasynaptic NMDA receptors. Neuron 43, 729-743 (2004).
54. Jourdain, P. et al. Glutamate exocytosis from astrocytes controls synaptic strength. Nat. Neurosci. 10, 331-339 (2007).
55. Fiacco, T.A. & McCarthy, K.D. Intracellular astrocyte calcium waves in situ increase the frequency of spontaneous AMPA receptor currents in CA1 pyramidal neurons. J. Neurosci. 24, 722-732 (2004).
56. Liu, Y. et al. NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J. Neurosci. 27, 2846-2857 (2007).
57. 2+ stores in astrocytes. J. Neurosci. Res. 76, 86-97 (2004).
58. Montana, V., Ni, Y., Sunjara, V., Hua, X. & Parpura, V. Vesicular glutamate transporter-dependent glutamate release from astrocytes. J. Neurosci. 24, 2633-2642 (2004).
59. Fiacco, T.A. et al. Selective stimulation of astrocyte calcium in situ does not affect neuronal excitatory synaptic activity. Neuron 54, 611-626 (2007).
60. Pascual, O. et al. Astrocytic purinergic signaling coordinates synaptic networks. Science 310, 113-116 (2005).
61. Danbolt, N.C. Glutamate uptake. Prog. Neurobiol. 65, 1-105 (2001).
62. Phillis, J.W., Ren, J. & O'Regan, M.H. Transporter reversal as a mechanism of glutamate release from the ischemic rat cerebral cortex: studies with DL-threo-β-benzyloxyaspartate. Brain Res. 868, 105-112 (2000).
63. Jabaudon, D. et al. Inhibition of uptake unmasks rapid extracellular turnover of glutamate of nonvesicular origin. Proc. Natl. Acad. Sci. USA 96, 8733-8738 (1999).
64. Cavelier, P. & Attwell, D. Tonic release of glutamate by a DIDS-sensitive mechanism in rat hippocampal slices. J. Physiol. (Lond.) 564, 397-410 (2005).
65. Takahashi, M. et al. The role of glutamate transporters in glutamate homeostasis in the brain. J. Exp. Biol. 200, 401-409 (1997).
66. Ottersen, O.P., Laake, J.H., Reichelt, W., Haug, F.M. & Torp, R. Ischemic disruption of glutamate homeostasis in brain: quantitative immunocytochemical analyses. J. Chem. Neuroanat. 12, 1-14 (1996).
67. Choi, D.W., Maulucci-Gedde, M. & Kriegstein, A.R. Glutamate neurotoxicity in cortical cell culture. J. Neurosci. 7, 357-368 (1987).
68. Hamann, M., Rossi, D.J., Marie, H. & Attwell, D. Knocking out the glial glutamate transporter GLT-1 reduces glutamate uptake but does not affect hippocampal glutamate dynamics in early simulated ischaemia. Eur. J. Neurosci. 15, 308-314 (2002).
69. Hamann, M., Rossi, D.J., Mohr, C., Andrade, A.L. & Attwell, D. The electrical response of cerebellar Purkinje neurons to simulated ischaemia. Brain 128, 2408-2420 (2005).
70. Mitani, A. & Tanaka, K. Functional changes of glial glutamate transporter GLT-1 during ischemia: an in vivo study in the hippocampal CA1 of normal mice and mutant mice lacking GLT-1. J. Neurosci. 23, 7176-7182 (2003).
71. Ouyang, Y.B., Voloboueva, L.A., Xu, L.J. & Giffard, R.G. Selective dysfunction of hippocampal CA1 astrocytes contributes to delayed neuronal damage after transient forebrain ischemia. J. Neurosci. 27, 4253-4260 (2007).
72. Gebhardt, C., Korner, R. & Heinemann, U. Delayed anoxic depolarizations in hippocampal neurons of mice lacking the excitatory amino acid carrier 1. J. Cereb. Blood Flow Metab. 22, 569-575 (2002).
73. Gorovits, R., Avidan, N., Avisar, N., Shaked, I. & Vardimon, L. Glutamine synthetase protects against neuronal degeneration in injured retinal tissue. Proc. Natl. Acad. Sci. USA 94, 7024-7029 (1997).
74. Rao, V.L. et al. Antisense knockdown of the glial glutamate transporter GLT-1, but not the neuronal glutamate transporter EAAC1, exacerbates transient focal cerebral ischemia-induced neuronal damage in rat brain. J. Neurosci. 21, 1876-1883 (2001).
75. Zhang, M. et al. The upregulation of glial glutamate transporter-1 participates in the induction of brain ischemic tolerance in rats. J. Cereb. Blood Flow Metab. 27, 1352-1368 (2007).
76. Rothstein, J.D. et al. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433, 73-77 (2005).
77. Shaked, I., Ben Dror, I. & Vardimon, L. Glutamine synthetase enhances the clearance of extracellular glutamate by the neural retina. J. Neurochem. 83, 574-580 (2002).
78. Hoshi, A., Nakahara, T., Kayama, H. & Yamamoto, T. Ischemic tolerance in chemical preconditioning: possible role of astrocytic glutamine synthetase buffering glutamate-mediated neurotoxicity. J. Neurosci. Res. 84, 130-141 (2006).
79. Kimelberg, H.K. Astrocytic swelling in cerebral ischemia as a possible cause of injury and target for therapy. Glia 50, 389-397 (2005).
80. Kimelberg, H.K., Goderie, S.K., Higman, S., Pang, S. & Waniewski, R.A. Swelling-induced release of glutamate, aspartate, and taurine from astrocyte cultures. J. Neurosci. 10, 1583-1591 (1990).
81. Seki, Y., Feustel, P.J., Keller, R.W. Jr., Tranmer, B.I. & Kimelberg, H.K. Inhibition of ischemia-induced glutamate release in rat striatum by dihydrokinate and an anion channel blocker. Stroke 30, 433-440 (1999).
82. - currents in cultured rat astrocytes. J. Physiol. (Lond.) 572, 677-689 (2006).
83. Martineau, M., Baux, G. & Mothet, J.P. D-Serine signalling in the brain: friend and foe. Trends Neurosci. 29, 481-491 (2006).
84. Wolosker, H. D-Serine regulation of NMDA receptor activity. Sci. STKE [online] 2006, e41 (2006).
85. Contreras, J.E. et al. Role of connexin-based gap junction channels and hemichannels in ischemia-induced cell death in nervous tissue. Brain Res. Brain Res. Rev. 47, 290-303 (2004).
86. Connors, B.W. & Long, M.A. Electrical synapses in the mammalian brain. Annu. Rev. Neurosci. 27, 393-418 (2004).
87. Thompson, R.J., Zhou, N. & MacVicar, B.A. Ischemia opens neuronal gap junction hemichannels. Science 312, 924-927 (2006).
88. Ye, Z.C., Wyeth, M.S., Baltan-Tekkok, S. & Ransom, B.R. Functional hemichannels in astrocytes: a novel mechanism of glutamate release. J. Neurosci. 23, 3588-3596 (2003).
89. Contreras, J.E. et al. Metabolic inhibition induces opening of unapposed connexin 43 gap junction hemichannels and reduces gap junctional communication in cortical astrocytes in culture. Proc. Natl. Acad. Sci. USA 99, 495-500 (2002).
90. Cotrina, M.L. et al. Astrocytic gap junctions remain open during ischemic conditions. J. Neurosci. 18, 2520-2537 (1998).
91. Rana, S. & Dringen, R. Gap junction hemichannel-mediated release of glutathione from cultured rat astrocytes. Neurosci. Lett. 415, 45-48 (2007).
92. Lin, J.H.-C. et al. Gap-junction-mediated propagation and amplification of cell injury. Nat. Neurosci. 1, 494-500 (1998).
93. Martins-Ferreira, H., Nedergaard, M. & Nicholson, C. Perspectives on spreading depression. Brain Res. Brain Res. Rev. 32, 215-234 (2000).
94. Rawanduzy, A., Hansen, A., Hansen, T.W. & Nedergaard, M. Effective reduction of infarct volume by gap junction blockade in a rodent model of stroke. J. Neurosurg. 87, 916-920 (1997).
95. Wygoda, M.R. et al. Protection of herpes simplex virus thymidine kinase-transduced cells from ganciclovir-mediated cytotoxicity by bystander cells: the Good Samaritan effect. Cancer Res. 57, 1699-1703 (1997).
96. Andrade-Rozental, A.F. et al. Gap junctions: the "kiss of death" and the "kiss of life". Brain Res. Brain Res. Rev. 32, 308-315 (2000).
97. Cusato, K. et al. Gap junctions mediate bystander cell death in developing retina. J. Neurosci. 23, 6413-6422 (2003).
98. Herve, J.C., Bourmeyster, N., Sarrouilhe, D. & Duffy, H.S. Gap junctional complexes: From partners to functions. Prog. Biophys. Mol. Biol. 94, 29-65 (2007).
99. Figiel, M., Allritz, C., Lehmann, C. & Engele, J. Gap junctional control of glial glutamate transporter expression. Mol. Cell. Neurosci. 35, 130-137 (2007).
100. Lin, J.H. et al. Connexin mediates gap junction-independent resistance to cellular injury. J. Neurosci. 23, 430-441 (2003).